Mr. Ruffcorn is a Vice President in Houlihan Lokey’s Business Services Group, where he primarily focuses on advising clients in the pharma services and commercialization industry on sellside and buyside M&A engagements. He is based in the firm’s Atlanta office.
Mr. Ruffcorn’s notable recent transactions include advising Avant Healthcare on its sale to Real Chemistry; OPEN Health on its acquisition of The CM Group; RevHealth on its sale to WindRose Health Investors; OPEN Health on its sale to Astorg; Fishawack Health on its acquisition of Avalere Health; Novo Holdings on its acquisition of Medical Knowledge Group; Intouch Group on its sale to Eversana; and The Lockwood Group on its investment from Ares.
Prior to joining Houlihan Lokey, Mr. Ruffcorn worked at Truist Securities, where he focused on M&A and debt and equity financings. He also spent time at Harbert Management Corporation’s Mezzanine Lending Fund, where he helped deploy subordinated debt and equity investments.
Mr. Ruffcorn holds a B.B.A. in Finance from the Terry College of Business at the University of Georgia.